Advertisement

Topics

Actelion Pharmaceuticals Ltd: Actelion provides an update on the Phase III IMPACT program with cadazolid in CDAD

01:04 EDT 8 Jun 2017 | FinanzNachrichten

Actelion Pharmaceuticals Ltd / Actelion provides an update on the Phase III IMPACT program with cadazolid in CDAD . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely res...

Original Article: Actelion Pharmaceuticals Ltd: Actelion provides an update on the Phase III IMPACT program with cadazolid in CDAD

NEXT ARTICLE

More From BioPortfolio on "Actelion Pharmaceuticals Ltd: Actelion provides an update on the Phase III IMPACT program with cadazolid in CDAD"

Quick Search
Advertisement
 

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...